Medicalgorithmics S.A. (WSE:MDG)
Poland · Delayed Price · Currency is PLN 27.25
+1.05 (4.01%)
Jun 16, 2026, 3:05 PM CET
Medicalgorithmics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Medicalgorithmics stock has a consensus rating of "Strong Buy" and an average price target of zł 41.35. The average 1-year stock price forecast is 51.74% higher than the current stock price, while the lowest is zł 38.00 (+39.45%) and the highest is zł 44.70 (+64.04%).
Price Target: zł 41.35 (+51.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Medicalgorithmics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Oct '25 | Nov '25 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
46.30M
from 30.99M
Increased by 49.43%
Revenue Next Year
68.89M
from 46.30M
Increased by 48.79%
EPS This Year
0.19
EPS Next Year
0.21
from 0.19
Increased by 7.89%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 46.3M | ||
| Avg | 46.3M | ||
| Low | 46.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 49.4% | ||
| Avg | 49.4% | ||
| Low | 49.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.19 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 7.9% | |
| Low | - |